Neuralink is poised to implant its Blindsight device in a human for the first time, subject to regulatory approval. Elon Musk explained that this brain interface aims to restore limited vision to fully blind patients, starting with low-resolution visual signals that improve over time. Musk anticipates a next-generation version by late 2026, featuring three times the capability, and a faster surgical robot that reduces implant time from 17 to 1.5 seconds. Blindsight could revolutionize blindness treatment and expand human sensory perception.